Photo credit: MSF/Alexandra SadokovaSTREAM Stage 2 study data submitted as part of Type II Variation to European Medicines Agency (EMA) and supplemental New Drug Application to US Food and Drug Administration (FDA) aim to support the full and traditional approval of SIRTURO® (bedaquiline) in the European Union and US, respectively.
Read the full press release here.
For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#35, 14 November 2023) with the latest TB advocacy and research updates.
Source : Johnson & Johnson
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.